Cream for therapy of dermatitis

Details Cream for therapy of dermatitis Cream for therapy of dermatitis

A - Human Necessities

61

K

A61K 31/16 (2006.01) A61K 8/97 (2006.01) A61K 31/10 (2006.01) A61K 31/60 (2006.01) A61P 7/00 (2006.01) A61P 17/00 (2006.01) A61Q 19/00 (2006.01)

Patent

CA 2480221

Technical Field: A therapeutic cream for dermatitis. Technical Problems: To provide a therapeutic cream efficacious for atopic dermatitis. Means for Resolution: Having a composition of 3% of Sophora radix, 2% of Curcuma aromatisca, 2% of Magnoliae cortex, 2% of Montan cortex, 1% of Baphicacanthes cusia, 1% of Borneolum syntheticum, 2% of Scutellariae radix, 2% of Phellodendri cortex, 1% of Angellica dahurica, 3% of lemon, 2% of Polygonum cuspidatum, 0.5% of Glycyrrhizae radix, 0.5% of Chidii rhizoma, 0.5% of Angelica acutiloba, 0.5% of salicylic acid, 0.5% of resorcin, 3% of lanoline, 3% of alcohol and 70.5% of white petrolactum. Owing to synergistic action of the antibacterial, antiviral, antiallergic, antiinflammtory, blood circulation- accelerating, antifungal, sterilizing and antipruritic effects of the above- described components, the effect of accelerating the penetration of active ingredients into the deep part under the skin of Chidii rhizoma and Angelica acutiloba, and the cornificaiton-accelerating effects of salicylic acid and resorcin, various dermatites such as atopic dermatitis can be innovatively treated. Major use: To be used in treating dermatitis, in particular, atopic dermatitis.

L'invention concerne une crème thérapeutique, destinée à lutter efficacement contre la dermatite atopique. Pour ce faire, une composition est mise en oeuvre, qui contient: 3 % de racine de sophora; 2 % de curcuma aromatique; 2 % de cortex de magnolia; 2 % de cortex de montan; 1 % de baphicacanthes cusia; 1 % de borneolum syntheticum; 2 % de racine de scutellaire; 2 % de cortex de phellodendre; 1 % d'angelica dahurica; 3 % de citron; 2 % de polygonum cuspidatum; 0,5 % de racine de glycyrrhiza; 0,5 % de chidii rhizoma; 0,5 % d'angelica acutiloba; 0,5 % d'acide salicilique; 0,5 % de résorcine; 3 % de lanoline; 3 % d'alcool; et 70,5 % de vaseline. Du fait de la synergie des effets antibactériens, antiviraux, anti-allergiques, anti-inflammatoires, stérilisants, antiprurigineux et de l'effet d'accélération de la circulation sanguine des éléments ci-décrits; de l'effet d'accélération de la pénétration cutanée du principe actif du chidii rhizoma et de l'angelica acutiloba dans la partie profonde sous-cutanée; et de l'effet d'accélération de la kératinisation de l'acide salicilique et de la résorcine, divers dermatites, telle que la dermatite atopique, peuvent être traitées de manière novatrice. La composition de l'invention peut être utilisée principalement pour traiter la dermatite, en particulier la dermatite atopique.

Affiliated with

Also associated with

Rating

Cream for therapy of dermatitis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cream for therapy of dermatitis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cream for therapy of dermatitis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2052917